Insomnia News and Research

Latest Insomnia News and Research

Many patients with sleep apnea or insomnia also have attention deficit disorder

People who have difficulty sleeping at night or staying awake during the day may suffer from more than just a sleep disorder.

25 Oct 2004

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.

13 Oct 2004

Women should aim for half an hour’s gentle exercise three times a week to aid their recovery from breast cancer

Currently the standard treatment for breast cancer involves no exercise therapy. However, the initial findings from a Cancer Research UK trial has shown that exercise therapy and lifestyle counselling could hasten recovery and improve the long-term physical and mental well being of women who are recovering from breast cancer.

8 Oct 2004

Minor depression is effectively treated with medication

Minor depression, an underdiagnosed and undertreated subset of major depressive disorder that affects upwards of 15 million Americans, can be effectively treated with a drug called a selective serotonin reuptake inhibitor (SSRI)

5 Oct 2004

Pregnant women are at higher risk for restless legs syndrome

Pregnant women are at higher risk for the occurrence or worsening of restless legs syndrome (RLS), a movement disorder that affects up to 10 percent of the general population, according to a study reported in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.

27 Sep 2004

New drug application to market ramelteon for insomnia

Takeda Global Research & Development Center announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) to market ramelteon (TAK-375), its investigational drug for insomnia.

26 Sep 2004

Histamine is key to narcolepsy

Narcolepsy is a disorder of sleep regulation that affects control of wakefulness and sleep and renders the patient subject to disabling sleepiness during the day.

23 Sep 2004

Prozac, Paxil, Wellbutrin, Zoloft, Celexa, Effexor, Luvox and Remeron should have "Black Box" warnings

A panel of experts has voted 15 to 8 in favour of the Federal Food and Drug Administration (FDA) adding black box warnings to certain medications used to treat depression in children and teenagers.

14 Sep 2004

Yentreve available in Europe for treatment of stress urinary incontinence

Yentreve (duloxetine hydrochloride) is now available in certain European countries, giving women suffering from moderate to severe stress urinary incontinence (SUI) a pharmaceutical treatment option for the first time.

13 Sep 2004

Lack of sleep may cause behavioral, learning and attention problems

Nine-year-old Fernando Perry-Mendoza may no longer need medication for attention-deficit/hyperactivity disorder thanks to the results of a sleep study at Doernbecher Children’s Hospital’s new Pediatric Sleep Program.

1 Sep 2004

Newly discovered protein switch may be key to understanding sleep disorders, anxiety, and depression

University of California researchers have found that a newly discovered protein switch which they named neuropeptide S appears to work in the brain to enhance wakefulness and reduce anxiety in laboratory animals. According to Rainer Reinscheid and his colleagues, the protein could help in the understanding of sleep disorders, anxiety, and depression.

18 Aug 2004

Insomnia drug market will exceed $5.6 billion in 2013

The new Pharmacor study entitled Insomnia finds that upcoming launches of three new drugs from Sepracor, Pfizer, and Sanofi-Aventis will drive the market.

16 Aug 2004

Typical warning signs for sleep apnea

Twenty percent of Americans have trouble sleeping. Millions of them have a common condition called obstructive sleep apnea, a respiratory disorder marked by upper airway obstruction, which causes brief interruptions of breathing during sleep.

31 Jul 2004

Prescription drugs from bogus Canadian website are all fake

A Food and Drug Administration (FDA) analysis of three commonly prescribed drugs purchased from a Web site advertised as Canadian showed that so-called "Canadian Generics" bought from the Web site were fake, substandard and potentially dangerous.

15 Jul 2004

From potent painkillers to humble cough syrups, the same medicines that help patients misused by teens

From potent painkillers to humble cough syrups, the same medicines that can help patients can also be misused to produce a high feeling. And they can hurt teens or hook them into addiction just as easily as other illicit drugs.

1 Jul 2004

U.S. Supreme Court to decide whether anti-drug laws should apply to the medicinal use of marijuana

The U.S. Supreme Court is to decide whether anti-drug laws should apply to the medicinal use of marijuana.

29 Jun 2004

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI).

29 Jun 2004

Drug may benefit patients suffering deep scarring after radiation treatment

Cancer patients who suffer from a progressive, deep scarring of tissue following radiation treatment might benefit from a drug that’s FDA-approved to treat vascular disease, according to a University of Rochester study published in this month’s Journal of Clinical Oncology.

10 Jun 2004

Advertising restrcitions on some over the counter medicines likely to be lifted

Regulations to remove the current ban on advertising certain over the counter (OTC) medicines to the public were laid in Parliament today

9 Jun 2004

Students win awards for research into liver disease, cancer and insomnia

Targeting a range of diseases and disorders, three University of Houston students won awards at a recent symposium for research in liver disease, cancer and insomnia.

2 Jun 2004

Insomnia News and Research

Latest Insomnia News and Research

Many patients with sleep apnea or insomnia also have attention deficit disorder

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

Women should aim for half an hour’s gentle exercise three times a week to aid their recovery from breast cancer

Minor depression is effectively treated with medication

Pregnant women are at higher risk for restless legs syndrome

New drug application to market ramelteon for insomnia

Histamine is key to narcolepsy

Prozac, Paxil, Wellbutrin, Zoloft, Celexa, Effexor, Luvox and Remeron should have "Black Box" warnings

Yentreve available in Europe for treatment of stress urinary incontinence

Lack of sleep may cause behavioral, learning and attention problems

Newly discovered protein switch may be key to understanding sleep disorders, anxiety, and depression

Insomnia drug market will exceed $5.6 billion in 2013

Typical warning signs for sleep apnea

Prescription drugs from bogus Canadian website are all fake

From potent painkillers to humble cough syrups, the same medicines that help patients misused by teens

U.S. Supreme Court to decide whether anti-drug laws should apply to the medicinal use of marijuana

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Drug may benefit patients suffering deep scarring after radiation treatment

Advertising restrcitions on some over the counter medicines likely to be lifted

Students win awards for research into liver disease, cancer and insomnia

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Insomnia News and Research

Latest Insomnia News and Research

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Newsletters you may be interested in